These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9815684

  • 1. Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
    Hanania EG, Deisseroth AB.
    Clin Cancer Res; 1997 Feb; 3(2):281-6. PubMed ID: 9815684
    [Abstract] [Full Text] [Related]

  • 2. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
    Hanania EG, Deisseroth AB.
    Cancer Gene Ther; 1994 Mar; 1(1):21-5. PubMed ID: 7621234
    [Abstract] [Full Text] [Related]

  • 3. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
    Guo C, Jin X.
    Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
    [Abstract] [Full Text] [Related]

  • 4. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
    Guo CB, Li YC, Jin XQ.
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A.
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 7. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T.
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [Abstract] [Full Text] [Related]

  • 8. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
    Nivens MC, Felder T, Galloway AH, Pena MM, Pouliot JJ, Spencer HT.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
    [Abstract] [Full Text] [Related]

  • 9. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit.
    Hanania EG, Fu S, Roninson I, Zu Z, Deisseroth AB.
    Gene Ther; 1995 Jun; 2(4):279-84. PubMed ID: 7552988
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH, Licht T, Merlino GT, Gottesman MM, Pastan I.
    Cancer Res; 1991 Oct 01; 51(19):5417-24. PubMed ID: 1680550
    [Abstract] [Full Text] [Related]

  • 11. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358
    [Abstract] [Full Text] [Related]

  • 12. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y, Zou YY, Xia WY, Hung MC.
    Cancer Gene Ther; 2004 Sep 01; 11(9):594-602. PubMed ID: 15272313
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma.
    Wang Y, Jin XQ, Wang S, Wang Q, Luo Q, Luo XJ.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):545-51. PubMed ID: 17085340
    [Abstract] [Full Text] [Related]

  • 14. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT, Yu D, Hung MC.
    Oncogene; 1997 Aug 18; 15(8):953-60. PubMed ID: 9285690
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
    Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC.
    Oncogene; 1996 Sep 19; 13(6):1359-65. PubMed ID: 8808711
    [Abstract] [Full Text] [Related]

  • 16. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 19; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
    Asano T, Kleinerman ES, Zwelling LA, Zhou Z, Fukunaga Y.
    Acta Oncol; 2005 Nov 19; 44(3):240-7. PubMed ID: 16076696
    [Abstract] [Full Text] [Related]

  • 18. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
    Gao HD, Lu P, Lu Y, Pang K, Xu HM, Wang SB, Chen JQ, Zhao SC.
    Zhonghua Zhong Liu Za Zhi; 2006 Aug 19; 28(8):583-5. PubMed ID: 17236551
    [Abstract] [Full Text] [Related]

  • 19. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N, Zhao SC, Adhikari D, Mineishi S, Sadelain M, Hilton J, Colvin M, Banerjee D, Bertino JR.
    Mol Ther; 2001 Jan 19; 3(1):88-96. PubMed ID: 11162315
    [Abstract] [Full Text] [Related]

  • 20. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.
    Cancer Gene Ther; 2009 Jan 19; 16(1):65-72. PubMed ID: 18654608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.